RAPT Therapeutics, Inc. (RAPT)

RAPT Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 15, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	895	213	855	672	1,085	485
Market Cap Growth	292.62%	-75.05%	27.19%	-38.08%	123.77%	-19.54%
Enterprise Value	790	120	677	484	874	362
Last Close Price	34.73	12.64	198.80	158.40	293.84	158.00
PS Ratio	-	-	-	440.09	284.61	96.19
PB Ratio	3.85	1.12	5.81	2.74	5.82	4.66
P/TBV Ratio	6.21	1.12	5.81	2.74	5.82	4.66
EV/Sales Ratio	-	-	-	317.25	229.33	71.83
Debt / Equity Ratio	0.02	0.02	0.05	0.04	-	-
Asset Turnover	-	-	-	0.01	0.02	0.05
Quick Ratio	11.76	4.78	7.28	17.51	19.77	9.50
Current Ratio	12.04	4.87	7.41	17.77	20.11	9.85
Return on Equity (ROE)	-85.37%	-77.09%	-59.56%	-38.86%	-47.63%	-59.66%
Return on Assets (ROA)	-51.35%	-41.13%	-36.13%	-23.07%	-27.24%	-32.67%
Return on Capital (ROIC)	-55.17%	-48.84%	-38.92%	-24.34%	-29.77%	-37.52%
Return on Capital Employed (ROCE)	-73.90%	-70.90%	-83.90%	-34.00%	-36.60%	-49.60%
Earnings Yield	-11.19%	-60.90%	-13.66%	-12.48%	-6.38%	-10.91%
FCF Yield	-9.18%	-39.12%	-11.49%	-10.66%	-5.69%	-8.43%
Buyback Yield / Dilution	-347.95%	-6.32%	-17.82%	-18.80%	-13.49%	-455.27%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q